Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,686	3,104	3,261	8,144	1,692	2,046
Market Cap Growth	-15.00%	-4.84%	-59.96%	381.32%	-17.32%	-5.00%
Enterprise Value	4,783	4,004	3,952	8,399	1,846	1,920
Last Close Price	23.72	19.97	21.26	53.09	11.03	13.17
PE Ratio	-	-	-	-	-	47.36
PS Ratio	5.84	4.78	6.43	24.69	4.66	6.64
PB Ratio	-68.76	-126.49	7.88	13.59	2.34	2.66
P/TBV Ratio	-	-	15.00	14.43	2.50	2.83
P/FCF Ratio	37.76	189.81	-	-	-	-
P/OCF Ratio	19.45	21.95	-	-	48.11	22.56
EV/Sales Ratio	7.58	6.17	7.80	25.46	5.08	6.23
EV/EBITDA Ratio	-	-	-	-	92.74	27.58
EV/EBIT Ratio	-	-	-	-	-	49.02
EV/FCF Ratio	48.99	244.90	-	-	-	-
Debt / Equity Ratio	-20.65	-41.58	2.62	0.66	0.45	0.11
Debt / EBITDA Ratio	-	-	-	-	16.07	1.18
Debt / FCF Ratio	11.34	62.40	-	-	-	-
Asset Turnover	0.37	0.38	0.32	0.26	0.33	0.31
Inventory Turnover	4.67	5.08	4.21	5.08	5.43	4.19
Quick Ratio	0.08	0.10	0.29	0.18	0.42	1.94
Current Ratio	0.16	0.17	0.51	1.04	0.58	2.40
Return on Equity (ROE)	-268.61%	-228.96%	-43.93%	-18.57%	-3.55%	5.55%
Return on Assets (ROA)	-7.73%	-7.62%	-7.49%	-5.84%	-0.78%	2.47%
Return on Capital (ROIC)	-10.40%	-10.55%	-9.62%	-7.16%	-0.92%	2.79%
Return on Capital Employed (ROCE)	-	-	-	-	-	4.60%
Earnings Yield	-12.02%	-14.33%	-6.80%	-1.50%	-1.54%	2.11%
FCF Yield	2.65%	0.53%	-19.97%	-1.80%	-19.03%	-7.97%
Dividend Yield	-	-	-	-	-	1.06%
Payout Ratio	-	-	-	-	-	54.64%
Buyback Yield / Dilution	1.22%	-0.98%	0.20%	-0.75%	0.72%	-0.23%
Total Shareholder Return	-	-0.98%	0.20%	-0.75%	0.72%	0.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.